| 3.1 Participant perception of change with treatment |
2 |
46 |
Risk Ratio (M‐H, Random, 95% CI) |
8.48 [2.21, 32.51] |
| 3.1.1 Citalopram |
1 |
26 |
Risk Ratio (M‐H, Random, 95% CI) |
9.00 [1.32, 61.24] |
| 3.1.2 Duloxetine |
1 |
20 |
Risk Ratio (M‐H, Random, 95% CI) |
8.00 [1.21, 52.69] |
| 3.2 Study withdrawal due to adverse events |
14 |
1315 |
Risk Ratio (M‐H, Random, 95% CI) |
2.00 [0.92, 4.34] |
| 3.2.1 Citalopram |
3 |
164 |
Risk Ratio (M‐H, Random, 95% CI) |
3.00 [0.13, 70.74] |
| 3.2.2 Dapoxetine |
2 |
383 |
Risk Ratio (M‐H, Random, 95% CI) |
7.64 [0.99, 58.71] |
| 3.2.3 Duloxetine |
1 |
20 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
| 3.2.4 Escitalopram |
1 |
276 |
Risk Ratio (M‐H, Random, 95% CI) |
2.00 [0.37, 10.74] |
| 3.2.5 Fluoxetine |
3 |
72 |
Risk Ratio (M‐H, Random, 95% CI) |
2.59 [0.34, 19.59] |
| 3.2.6 Fluvoxamine |
1 |
15 |
Risk Ratio (M‐H, Random, 95% CI) |
1.54 [0.09, 25.86] |
| 3.2.7 Paroxetine |
4 |
281 |
Risk Ratio (M‐H, Random, 95% CI) |
1.76 [0.35, 8.91] |
| 3.2.8 Sertraline |
3 |
104 |
Risk Ratio (M‐H, Random, 95% CI) |
0.43 [0.05, 3.56] |
| 3.3 Adverse events |
13 |
1204 |
Risk Ratio (M‐H, Random, 95% CI) |
2.00 [1.44, 2.78] |
| 3.3.1 Citalopram |
2 |
106 |
Risk Ratio (M‐H, Random, 95% CI) |
3.00 [0.51, 17.57] |
| 3.3.2 Clomipramine |
1 |
42 |
Risk Ratio (M‐H, Random, 95% CI) |
4.40 [1.06, 18.32] |
| 3.3.3 Dapoxetine |
2 |
356 |
Risk Ratio (M‐H, Random, 95% CI) |
2.54 [1.34, 4.81] |
| 3.3.4 Duloxetine |
1 |
20 |
Risk Ratio (M‐H, Random, 95% CI) |
3.00 [0.37, 24.17] |
| 3.3.5 Escitalopram |
1 |
254 |
Risk Ratio (M‐H, Random, 95% CI) |
1.69 [0.69, 4.15] |
| 3.3.6 Fluoxetine |
4 |
140 |
Risk Ratio (M‐H, Random, 95% CI) |
2.50 [1.29, 4.86] |
| 3.3.7 Paroxetine |
1 |
155 |
Risk Ratio (M‐H, Random, 95% CI) |
2.50 [0.91, 6.90] |
| 3.3.8 Sertraline |
3 |
131 |
Risk Ratio (M‐H, Random, 95% CI) |
1.33 [0.74, 2.39] |
| 3.4 Intravaginal ejaculatory latency time |
14 |
576 |
Mean Difference (IV, Random, 95% CI) |
3.36 [1.62, 5.10] |
| 3.4.1 Citalopram |
3 |
157 |
Mean Difference (IV, Random, 95% CI) |
4.85 [3.14, 6.56] |
| 3.4.2 Duloxetine |
1 |
20 |
Mean Difference (IV, Random, 95% CI) |
1.52 [0.80, 2.24] |
| 3.4.3 Fluoxetine |
5 |
149 |
Mean Difference (IV, Random, 95% CI) |
2.46 [1.52, 3.39] |
| 3.4.4 Fluvoxamine |
1 |
12 |
Mean Difference (IV, Random, 95% CI) |
0.59 [‐0.35, 1.53] |
| 3.4.5 Paroxetine |
3 |
107 |
Mean Difference (IV, Random, 95% CI) |
6.51 [0.33, 12.68] |
| 3.4.6 Sertraline |
4 |
131 |
Mean Difference (IV, Random, 95% CI) |
2.55 [1.54, 3.56] |
| 3.5 Depression |
1 |
14 |
Risk Ratio (M‐H, Random, 95% CI) |
2.00 [0.23, 17.34] |
| 3.5.1 Fluoxetine |
1 |
14 |
Risk Ratio (M‐H, Random, 95% CI) |
2.00 [0.23, 17.34] |
